BAY Stock Chart & Stats
zł210.50
zł0.00(0.00%)
At close: 4:00 PM EDT
zł210.50
zł0.00(0.00%)
Day’s Range― - ―
52-Week Rangezł75.00 - zł230.50
Previous CloseN/A
Volume0.00
Average Volume (3M)13.00
Market Cap
zł214.91B
Enterprise Valuezł81.83K
Total Cash (Recent Filing)zł5.08B
Total Debt (Recent Filing)zł38.43B
Price to Earnings (P/E)―
Beta0.53
Next Earnings
Nov 03, 2026EPS Estimate
2.06Next Dividend Ex-DateN/A
Dividend Yield0.22%
Share Statistics
EPS (TTM)-1.76
Shares Outstanding982,424,100
10 Day Avg. Volume0
30 Day Avg. Volume13
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.40
Price to Sales (P/S)0.80
P/FCF Ratio17.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
zł263.19Price Target Upside25.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)19.7
Revenue Forecast (FY)zł199.31B
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelBayer's dual focus in Pharmaceuticals and Crop Science provides durable revenue diversification across healthcare and agriculture. This reduces exposure to single-market cycles, leverages separate distribution channels and regulatory moats, and supports long-term cash generation and R&D reinvestment.
Cash GenerationConsistent positive operating and free cash flow despite recent net losses signals that core product sales convert to cash. Durable cash generation supports capital expenditure, R&D, dividend capacity and deleveraging options over the next several months, even if free cash flow is somewhat volatile.
High Gross MarginsSustained gross margins in the mid-50s to low-60s indicate strong underlying product economics and pricing power in key franchises. High gross margins provide a structural buffer against input cost shocks and fund R&D and commercialization, supporting medium-term margin recovery if operating costs are managed.
Bears Say
Elevated LeverageMulti-year leverage above equity limits financial flexibility and raises interest and refinancing risk. Elevated debt constrains strategic options such as large M&A or accelerated buybacks, increases sensitivity to macro shocks, and can pressure credit metrics and investment capacity over the medium term.
Multi-year Profitability WeaknessSustained net losses and inconsistent operating margins undermine return metrics and reinvestment capacity. Protracted profitability weakness can erode ROE, challenge dividend sustainability, and require either cost restructuring or higher-margin product launches to restore durable earnings power over the coming quarters.
Weak Revenue TrendSeveral years of flat-to-declining revenue before a recent TTM uptick suggest structural growth challenges from product lifecycles and cyclical Crop Science demand. Without steady top-line momentum, sustaining margins and funding innovation will be harder, leaving execution and new launches critical.
Bayer News
BAY FAQ
What was Bayer’s price range in the past 12 months?
Bayer lowest stock price was zł75.00 and its highest was zł230.50 in the past 12 months.
What is Bayer’s market cap?
Bayer’s market cap is zł214.91B.
When is Bayer’s upcoming earnings report date?
Bayer’s upcoming earnings report date is Nov 03, 2026 which is in 35 days.
How were Bayer’s earnings last quarter?
Bayer released its earnings results on Aug 04, 2026. The company reported zł4.155 earnings per share for the quarter, beating the consensus estimate of zł3.363 by zł0.792.
Is Bayer overvalued?
According to Wall Street analysts Bayer’s price is currently Undervalued.
Does Bayer pay dividends?
Bayer pays a Annually dividend of zł0.474 which represents an annual dividend yield of 0.22%. See more information on Bayer dividends here
What is Bayer’s EPS estimate?
Bayer’s EPS estimate is 2.06.
How many shares outstanding does Bayer have?
Bayer has 982,424,100 shares outstanding.
What happened to Bayer’s price movement after its last earnings report?
Bayer reported an EPS of zł4.155 in its last earnings report, beating expectations of zł3.363. Following the earnings report the stock price went up 2.683%.
Which hedge fund is a major shareholder of Bayer?
Currently, no hedge funds are holding shares in PL:BAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bayer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
zł263.19 (25.03% Upside)
zł263.19 (25.03% Upside)
Blogger Sentiment
Bullish
PL:BAY Sentiment 67%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth zł5.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
81.65%
12-Months-Change
Fundamentals
Return on Equity
0.22%
Trailing 12-Months
Asset Growth
1.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Bayer
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
BAY Stock 12 Month Forecast
Average Price Target
zł263.19
▲(25.03% Upside)